Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
DURECT Corporation, a biopharmaceutical company, develops medicines based on its epigenetic regulator program. The company's lead product larsucosterol (DUR-928), an endogenous, orally bioavailable small molecule that is in Phase IIb clinical trial to play a regulatory role in lipid metabolism, stress and inflammatory responses, and cell death and survival to treat alcohol-associated hepatitis, as well as completed Phase Ib clinical trial to treat patients with nonalcoholic steatohepatitis. It also offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. In addition, the company offers POSIMIR, a post-surgical pain product to deliver bupivacaine over three days in adults; and Methydur to treat attention deficit hyperactivity disorder. It markets and sells its ALZET lines through direct sales force in the United States, as well as through a network of distributors in other countries. The company has strategic collaboration and other agreements with Virginia Commonwealth University Intellectual Property Foundation; Indivior UK Ltd.; and Innocoll Pharmaceuticals Limited. DURECT Corporation was incorporated in 1998 and is headquartered in Cupertino, California. more
Time Frame | DRRX | Sector | S&P500 |
---|---|---|---|
1-Week Return | -6.58% | -1.8% | -0.77% |
1-Month Return | -40.23% | -3.48% | 0.71% |
3-Month Return | -50.89% | -7.2% | 8.81% |
6-Month Return | -46.83% | -1.54% | 12.32% |
1-Year Return | 27.42% | 8.39% | 30.57% |
3-Year Return | -92.13% | 6.07% | 29.21% |
5-Year Return | -95.96% | 44.07% | 91.95% |
10-Year Return | -90.82% | 106.3% | 196.04% |
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | 29.56M | 30.11M | 13.98M | 19.28M | 8.55M | [{"date":"2019-12-31","value":98.18,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":46.42,"profit":true},{"date":"2022-12-31","value":64.04,"profit":true},{"date":"2023-12-31","value":28.39,"profit":true}] |
Cost of Revenue | 4.14M | 1.41M | 1.96M | 1.59M | 1.72M | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":33.94,"profit":true},{"date":"2021-12-31","value":47.19,"profit":true},{"date":"2022-12-31","value":38.33,"profit":true},{"date":"2023-12-31","value":41.44,"profit":true}] |
Gross Profit | 25.42M | 28.70M | 12.02M | 17.70M | 6.83M | [{"date":"2019-12-31","value":88.56,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":41.88,"profit":true},{"date":"2022-12-31","value":61.64,"profit":true},{"date":"2023-12-31","value":23.8,"profit":true}] |
Gross Margin | 85.99% | 95.33% | 86.01% | 91.76% | 79.91% | [{"date":"2019-12-31","value":90.2,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":90.23,"profit":true},{"date":"2022-12-31","value":96.26,"profit":true},{"date":"2023-12-31","value":83.83,"profit":true}] |
Operating Expenses | 44.57M | 41.32M | 46.30M | 52.78M | 43.72M | [{"date":"2019-12-31","value":84.45,"profit":true},{"date":"2020-12-31","value":78.29,"profit":true},{"date":"2021-12-31","value":87.72,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":82.83,"profit":true}] |
Operating Income | (19.15M) | (12.62M) | (34.27M) | (35.08M) | (36.88M) | [{"date":"2019-12-31","value":-1915100000,"profit":false},{"date":"2020-12-31","value":-1261500000,"profit":false},{"date":"2021-12-31","value":-3427300000,"profit":false},{"date":"2022-12-31","value":-3508200000,"profit":false},{"date":"2023-12-31","value":-3688400000,"profit":false}] |
Total Non-Operating Income/Expense | (2.85M) | (3.44M) | (3.98M) | (502.00K) | 9.79M | [{"date":"2019-12-31","value":-29.14,"profit":false},{"date":"2020-12-31","value":-35.12,"profit":false},{"date":"2021-12-31","value":-40.67,"profit":false},{"date":"2022-12-31","value":-5.13,"profit":false},{"date":"2023-12-31","value":100,"profit":true}] |
Pre-Tax Income | (20.58M) | (14.34M) | (36.27M) | (35.33M) | (27.62M) | [{"date":"2019-12-31","value":-2057800000,"profit":false},{"date":"2020-12-31","value":-1433500000,"profit":false},{"date":"2021-12-31","value":-3626500000,"profit":false},{"date":"2022-12-31","value":-3533300000,"profit":false},{"date":"2023-12-31","value":-2762400000,"profit":false}] |
Income Taxes | 2.21M | (11.81M) | 1.86M | 251.00K | (19.89K) | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":-534.52,"profit":false},{"date":"2021-12-31","value":84.16,"profit":true},{"date":"2022-12-31","value":11.36,"profit":true},{"date":"2023-12-31","value":-0.9,"profit":false}] |
Income After Taxes | (22.79M) | (2.52M) | (38.13M) | (35.58M) | (27.60M) | [{"date":"2019-12-31","value":-2278800000,"profit":false},{"date":"2020-12-31","value":-252200000,"profit":false},{"date":"2021-12-31","value":-3812500000,"profit":false},{"date":"2022-12-31","value":-3558400000,"profit":false},{"date":"2023-12-31","value":-2760410500,"profit":false}] |
Income From Continuous Operations | (20.58M) | (14.34M) | (36.27M) | (35.33M) | (36.65M) | [{"date":"2019-12-31","value":-2057800000,"profit":false},{"date":"2020-12-31","value":-1433500000,"profit":false},{"date":"2021-12-31","value":-3626500000,"profit":false},{"date":"2022-12-31","value":-3533300000,"profit":false},{"date":"2023-12-31","value":-3665200000,"profit":false}] |
Income From Discontinued Operations | 13.75M | 13.75M | - | - | - | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Net Income | (22.79M) | (2.52M) | (38.13M) | (35.58M) | (27.62M) | [{"date":"2019-12-31","value":-2278800000,"profit":false},{"date":"2020-12-31","value":-252200000,"profit":false},{"date":"2021-12-31","value":-3812500000,"profit":false},{"date":"2022-12-31","value":-3558400000,"profit":false},{"date":"2023-12-31","value":-2762400000,"profit":false}] |
EPS (Diluted) | (1.10) | (0.70) | (1.60) | (1.56) | (1.13) | [{"date":"2019-12-31","value":-110,"profit":false},{"date":"2020-12-31","value":-70,"profit":false},{"date":"2021-12-31","value":-160,"profit":false},{"date":"2022-12-31","value":-156,"profit":false},{"date":"2023-12-31","value":-113,"profit":false}] |
These ratios help you determine the liquidity of the company. Higher is better.
DRRX | |
---|---|
Cash Ratio | 0.51 |
Current Ratio | 0.71 |
Quick Ratio | 0.60 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
DRRX | |
---|---|
ROA (LTM) | -39.70% |
ROE (LTM) | -299.88% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
DRRX | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 0.95 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.05 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
DRRX | |
---|---|
Trailing PE | NM |
Forward PE | NM |
P/S (TTM) | 2.85 |
P/B | 20.26 |
Price/FCF | NM |
EV/R | 3.26 |
EV/Ebitda | NM |
PEG | NM |
Durect Corporation (DRRX) share price today is $0.771
Yes, Indians can buy shares of Durect Corporation (DRRX) on Vested. To buy Durect Corporation from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in DRRX stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of Durect Corporation (DRRX) via the Vested app. You can start investing in Durect Corporation (DRRX) with a minimum investment of $1.
You can invest in shares of Durect Corporation (DRRX) via Vested in three simple steps:
The 52-week high price of Durect Corporation (DRRX) is $1.88. The 52-week low price of Durect Corporation (DRRX) is $0.48.
The price-to-earnings (P/E) ratio of Durect Corporation (DRRX) is
The price-to-book (P/B) ratio of Durect Corporation (DRRX) is 20.26
The dividend yield of Durect Corporation (DRRX) is 0.00%
The market capitalization of Durect Corporation (DRRX) is $24.66M
The stock symbol (or ticker) of Durect Corporation is DRRX